Main: (02) 9767 6799
Concord Hospital and Concord Cancer Centre consider scientific research as essential in order to improve the survival rates and quality of life for patients with cancer. Access to cutting-edge research directly impacts cancer outcomes by giving doctors and nurses the latest information and expertise.
Towards the end of 2021, the Concord Cancer Centre will move into a new, purpose-built facility with new clinics, a day unit, a dedicated clinical research suite, and an inpatient ward. Staffing and roles will be adjusted to provide world class service through new clinical pathways and workflows.
Research facilities with high academic standards benefits patients, attracting top academic physicians, researchers and trainees nationally who co-locate at the Concord Cancer Centre to improve patient's health outcomes.
Concord Hospital and Concord Cancer Centre strive towards expanding patient's access to clinical trials, screening patients carefully to ensure successful recruitment to relevant studies. They also raise staff awareness of trials so patients have the opportunity to choose whether to be involved.
Cancer Institute NSW provides funds to Cancer and Palliative Care Clinical Trials units for enrolling patients in clinical trials.
Concord Cancer Centre also has well established clinical trials departments in Medical Oncology, Haematology and Palliative care, where patients themselves have access to the latest treatments.
Concord Repatriation General Hospital also benefits from its links with research across Sydney Local Health District.
The COVID-19 pandemic has presented a number of specific challenges in clinical trials. It has required staff to adapt work practices, sustain ongoing clinical trials therapies and maintain patient safety.